CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • À¯ÁØȯ
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ¿°Áõ¼ºÀåÁúȯ, ´ëÀå¾Ï, Ä¡·á³»½Ã°æ
  • Á÷ À§: ºÎ±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
257 (±¹¿Ü)SCIE Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic cancer
256 (±¹¿Ü)SCI Fecal calprotectin as a non-invasive biomarker for intestinal involvement of Beh?t's disease
255 (±¹¿Ü)SCIE Does a Pre-Training Program Influence Colonoscopy Proficiency during Fellowship?
254 (±¹¿Ü)SCI Clinical response to dorsal duct drainage via the minor papilla in refractory obstructing chronic calcific pancreatitis
253 (±¹¿Ü)SCIE Tumor characteristics associated with malignant large bowel obstruction in stage IV colorectal cancer patients undergoing chemotherapy
252 (±¹¿Ü)SCIE Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma
251 (±¹¿Ü)SCIE Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients.
250 (±¹¿Ü)SCIE Suppressed Helicobacter pylori-associated gastric tumorigenesis in Fat-1 transgenic mice producing endogenous ¥ø-3 polyunsaturated fatty acids.
249 (±¹³»)SCOPUS ¾Ï¼ºÇ÷ÀüÀ» µ¿¹ÝÇÑ Ä§À±¼º °£¾ÏÀ¸·Î ¿ÀÁøµÈ ¹®¸Æ¿°À¸·Î ÀÎÇÑ ±Þ¼º °£°æ»ö
248 (±¹¿Ü)SCIE Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 18 19 20 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729